Skip to main content Accessibility help
×
Home
  • Print publication year: 2009
  • Online publication date: December 2009

Chapter 19 - Refractory narrow complex tachycardia in infancy

References

1. TrohmanRG. Supraventricular tachycardia: implications for the intensivist. Critical Care Med 2000; 28(10): N129–35.
2. PfammatterJP, BauersfeldU. Safety issues in the treatment of paediatric supraventricular tachycardias. Drug Safety 1998;18(S): 345–56.
3. DorostkarPC, SilkaMJ, MoradyF, DickM. Clinical course of persistent junctional reciprocating tachycardia. J Am Coll Cardiol 1999; 33(2): 366–75.
4. BrockmeierK, UlmerHE, HesslingG. Termination of atrial reentrant tachycardia by using transoesophageal atrial pacing. J Electrcardiol 2002; 35: 159–63.
5. PakerDL, BardyGH, WorleySJet al. Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. Am J Cardiol 1986; 57: 563–70.
6. SarubbiB, MustoB, DucceschiVet al. Congenital junctional ectopic tachycardia in children and adolescents: a 20 year experience based study. Heart 2002; 88(2): 188–90.
7. EngelsteinED, LippmanN, SteinKMet al. Arrhythmias/EP Intervention/pacing: mechanism-specific effects of adenosine on atrial tachycardia. Circulation 1994; 89(6): 2645–54.
8. HesslingG, BrockmeierK, UlmerH. Transoesophageal electrocardiography and atrial pacing in children. J Electrocardiol 2002; 35: 143–9.
9. GlatterKA, ChengJ, DorostkarPet al. Electrophysiological effects of adenosine in patients with supraventricular tachycardia. Circulation 1999; 99: 1034–40.
10. PellegA, PennockRS, KutalekSP. Proarrhythmic effects of adenosine: one decade of clinical data. Am J Ther 2002; 9: 141–7.
11. SherwoodMC, LauKC, ShollerGF. Adenosine in the management of supraventricular tachycardia in children. J Paediatr Child Health 1998; 34(1): 53–6.
12. FriedmanFD. Interosseous adenosine for the termination of supraventricular tachycardia in an infant. Ann Int Med 1996; 28(3): 356–8.
13. EngelsteinED, LippmanN, SteinKM, LermanBB. Arrhythmias/EP intervention/pacing: mechanism-specific effects of adenosine on atrial tachycardia. Circulation 1994; 89(6): 2645–54.
14. RhodesLA, WalshEP, SaulJP. Conversion of atrial flutter in pediatric patients by transoesophageal atrial pacing: a safe, effective, minimally invasive procedure. Am Heart J 1995; 130: 323–7.
15. VillainE, BonnetD, AcarPet al. Recommendations for the treatment of supraventricular tachycardia in infants. Arch de Ped 1998; 5(2): 133–8.
16. PfammatterJP, StockerFP. Role of digoxin in the long term treatment of supraventricular tachycardias in infancy. Eur J Pediatr 1998; 157: 101–6.
17. SreeramN, WrenC. Supraventricular tachycardia in infants: response to treatment. Arch Dis Child 1990; 65(1): 127–9.
18. WeindlingSN, SaulJP, WalshEP. Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J 1996; 131: 66–72.
19. O’SullivanJJ, GardinerHG, WrenC. Digoxin or flecanide for prophylaxis of supraventricular tachycardia in infants. J Am Coll Cardiol 1995; 26: 991–4.
20. TortorielloTA, SnyderCS, SmithEOet al. Frequency of recurrence among infants with supraventricular tachycardia and comparison of recurrence rates among those with and without preexcitation and among those with and without response to digoxin and/or propanolol therapy. Am J Cardiol 2003; 92(9): 1045–9.
21. MehtaAV, SubrahmanyamAB, AnandR. Long-term efficacy of atenolol for supraventricular tachycardia in children. Pediatr Cardiol 1996; 17(4): 231–6.
22. MehtaAV, Chidambaram. Efficacy and safety of oral and intravenous nadolol for supraventricular tachycardia in children. J Am Coll Cardiol 1992; 19(3): 630–5.
23. CelikerA, AyabakanC, OzerS, OzmeS. Sotalol in treatment of pediatric cardiac arrhythmias. Pediatr Int 2001; 43: 624–30.
24. MaragnesP, TippleM, FournierA. Effectiveness of oral sotalol for the treatment of pediatric arrhythmias. Am J Cardiol 1992; 69(8): 751–4.
25. PfammaterJP, PaulT, LehmanCet al. Efficacy and pro-arrhythmia of oral sotalol in pediatric patients. J Am Coll Cardiol 1995; 26: 1002–7.
26. KorenG. Interaction between digoxin and commonly co-administered drugs. Pediatrics 1985; 75(6): 1032–7.
27. McKeeMR. Amiodarone – an “old” drug with new recommendations. Curr Opin Pediatr 2003; 15: 193–9.
28. EtheridgeSP, CraigJE, ComptonSJ. Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants. Am Heart J 2001; 141: 105–10.
29. DragoF, MazzaA, GuccionePet al. Amiodarone used alone or in combination with propanolol; a very effective therapy for tachyarrhythmia in infants and children. Pediatr Cardiol 1998;19(6): 445–9.
30. FenrichAL, PerryJC, FriedmanRA. Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy. JACC 1995; 25(5): 1195–8.
31. CockrellJL, ScheinmanMM, TitusCet al. Safety and efficacy of oral flecainide therapy in patients with atrioventricular re-entrant tachycardia. Ann Int Med 1991; 114: 189–94.
32. PerryJC, GarsonA. Flecainide acetate for treatment of tachyarrhythmias in children:review of world literature on efficacy, safety and dosing. Am Heart J 1992; 124(6): 1614–21.
33. O’SullivanJJ, GardinerHM, WrenC. Digoxin or flecainide for prophylaxis or supraventricular tachycardia in infants? JACC 1995; 26(4): 991–4.
34. PriceJF, KerteszNJ, SnyderCSet al. Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age. 2002; 39(3): 517–20.
35. JanousekJ, ThomasP. Safety of oral propafenone in the treatment of arrhythmias in infants and children. Am J Cardiol 1998; 81(9): 1121–4.
36. HesslingG, BrockmeierK, RuedigerH, HerbertE. Electrophysiological efficacy of intravenous propafenone in terminating atrioventricular reentrant tachycardia in children. Am J Cardiol 2001; 87(6): 802–4.
37. MustoB, D’OnofrioA, CavallaroC, MustoA. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia. Circulation 1988; 78(4): 863–9.
38. Van StuijvenbergM, Beaufort-KrolGC, HaaksmaJ, Bink-BoelkensMT. Pharmacological treatment of young children with permanent junctional reciprocating tachycardia. Cardiol Young 2003; 13(5): 408–12.
39. EtheridgeSP, JuddVE. Supraventricular tachycardia in infancy: evaluation, management and follow up. Arch Pediatri Adolesc Med 1999; 153(3): 267–71.
40. LisowskiLA, VerheijenPM, BenatarAAet al. Atrial flutter in the perinatal age group: diagnosis, management and outcome. J Am Coll Cardiol 2000; 35(3): 771–7.
41. BalajiS, JohnsonTB, SadeRMet al. Management of atrial flutter after the Fontan procedure. J Am Coll Cardiol 1994; 23(5): 1209–15.
42. LucetV. Late atrial tachycardia after Fontan-type procedure. Cooperative study of 52 cases. Arch de Mal du Co Vaiss 2002; 95(5): 447–52.
43. Beaufort-KrolG, Bink-BoelkensM. Effectiveness of sotalol in children after surgery for congenital heart disease. Am J Cardiol 1997; 79(1): 92–4.
44. SalernoJC, KerteszNJ, FriedmanRA, FenrichAL. Clinical course of atrial ectopic tachycardia is age-dependent: results of treatment in children <3 or >3 years of age. J Am Coll Cardiol 2004; 43(3): 438–44.
45. BauersfeldU, GowR, HamiltonRM, IzukawaT. Treatment of atrial ectopic tachycardia in infants <6 months old. Am Heart J 1995; 129: 1145–8.
46. RosalesAM, WalshEP, WesselDL, TriedmanJK. Postoperative ectopic atrial tachycardia in children with congenital heart disease. Am J Cardiol 2001; 88(10): 1169–72.
47. WalshEP, SaulJP, ShollerGFet al. Evaluation of a staged treatment protocol for rapid automatic junctional tachycardia after operation for congenital heart disease. J Am Coll Cardiol 1997; 29(5): 1046–53.
48. LairdWP, SnyderCS, KerteszNJet al. Use of intravenous amiodarone for postoperative junctional ectopic tachycardia. Ped Cardiol 2003;24(2): 133–7.
49. BronzettiG, FormigariR, GiardiniAet al. Intravenous flecanide for the treatment of junctional ectopic tachycardia after surgery for congenital heart disease. Ann Thorac Surg 2003; 76(1): 148–51.
50. MandapatiR, ByrumCJ, KaveyREet al. Procainamide for rate control of postsurgical junctional tachycardia. Pediatr Cardiol 2000; 21(2): 123–8.
51. VillainE, VetterVL, GarciaJMet al. Evolving concepts in the management of congenital junctional tachycardia. A multicentre study. Circulation 1990; 81: 1544–9.
52. CilliersAM, du PlessisJP, ClurSBet al. Junctional ectopic tachycardia in six paediatric patients. Heart 1997; 78(4): 413–15.
53. PaulT, ReimerA, JanouesekJ, KallfelzHC. Efficacy and safety of propafenone in congenital junctional ectopic tachycardia. J Am Coll Cardiol 1992; 20(4): 911–14.
54. SarubbiB, MustoB, DucceschiVet al. Congenital junctional ectopic tachycardia in children and adolescents: a 20 year experience based study. Heart 2002; 88(2): 188–90.
55. ScheinmanM, CalkinsH, GillettePet al. NASPE policy statement on catheter ablation: personnel, policy, procedures and therapeutic recommendations. PACE 2003; 26: 789–99.
56. WalkerGM, McLeodK, BrownKLet al. Extracorporeal life support as a treatment for supraventricular tachycardia in infants. Ped Crit Care Med 2003; 4(1): 52–4.

Further reading

Books
Practical Management of Pediatric Cardiac Arrhythmias, eds. P C. Gillette and V L. Zeigler. U.S.A, Futura Publishing Co Inc..
Clinical Pediatric Arrhythmias, eds. P C. Gillette and, A. Garson. USA, W.B. Saunders Ltd

Books

Practical Management of Pediatric Cardiac Arrhythmias, eds. P C. Gillette and V L. Zeigler. U.S.A, Futura Publishing Co Inc..
Clinical Pediatric Arrhythmias, eds. P C. Gillette and, A. Garson. USA, W.B. Saunders Ltd